Production (Stage)
InspireMD, Inc.
NSPR
$2.53
$0.2510.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -21.55% | 7.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -21.55% | 7.68% | |||
| Cost of Revenue | -16.42% | 6.02% | |||
| Gross Profit | -37.74% | 13.29% | |||
| SG&A Expenses | 25.23% | 23.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.78% | 10.16% | |||
| Operating Income | -22.34% | -10.69% | |||
| Income Before Tax | -22.50% | -15.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.71% | -16.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.71% | -16.27% | |||
| EBIT | -22.34% | -10.69% | |||
| EBITDA | -22.28% | -10.72% | |||
| EPS Basic | -19.03% | -15.02% | |||
| Normalized Basic EPS | -30.71% | -4.81% | |||
| EPS Diluted | -19.03% | -15.02% | |||
| Normalized Diluted EPS | -30.71% | -4.81% | |||
| Average Basic Shares Outstanding | 2.26% | 1.08% | |||
| Average Diluted Shares Outstanding | 2.26% | 1.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||